The U.S. Food and Drug Administration (FDA) has approved the first artificial intelligence (AI) tool to predict breast cancer risk. Dr. Jeff Elton, the vice chairman at AI health-tech company ConcertAI joined LiveNOW's Christy Matino to discuss how it works.

See Full Page